Morgan Stanley raised the firm’s price target on McKesson (MCK) to $810 from $770 and keeps an Overweight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
- McKesson CEO sells $13.7M in common stock
- Oncology Institute names Kristin England chief administrative officer
- Synergy CHC secures retail deals with McKesson Canada, others
- Cardinal Health price target raised to $181 from $166 at Morgan Stanley
- McKesson’s Operational Strength and Strategic Acquisition Drive Positive Outlook